Other
Updated the "Related Patent Info."
New patent information relates to iPS cell technologies for the month of November 2019 has been updated. Please see Related Patent Info. for...
Other
New patent information relates to iPS cell technologies for the month of November 2019 has been updated. Please see Related Patent Info. for...
results 1 - 10 of 42
Other
Our office will be closed for winter holidays from Saturday 28th December 2019 to Sunday 5th January 2020. Please understand that our earlie...
License-Out
We have executed a non-exclusive license agreement for internal research with MSD (a trademark of Merck & Co., Inc., Kenilworth, NJ, U.S...
License-Out
We have executed a non-exclusive license agreement for internal research with Celgenyx, Inc. (Potomac, U.S.A.) under the patents on iPS cell...
License-Out
We have executed a worldwide non-exclusive license agreement with Heartseed Inc. (Tokyo, Japan) for allowing them to provide iPS cell-derive...
License-In
We have entered into an agreement with Yokohama City University to collaborate for contributing to society with the research results produce...
Other
New patent information relates to iPS cell technologies for the month of October 2019 has been updated. Please see Related Patent Info. for ...
License-Out
We have executed a non-exclusive license agreement with Accellta Ltd. (Haifa, Israel) for allowing them to provide services using iPS cells ...
License-Out
We have executed a worldwide license agreement with Aspen Neuroscience, Inc. (San Diego, U.S.A) for the use of iPS cell-derived dopamine neu...
License-Out
We have executed a non-exclusive license agreement with IMBA (Vienna, Austria) for allowing them to provide iPS cells for user's research pu...